Ketamine Therapy With Heart Disease: Who Qualifies (2026)

Of every category of medical history I review during intake, cardiac is the one that produces the most individualized decisions. Some patients with a cardiac history are clearly appropriate for at-home ketamine treatment. Some clearly aren't. And a meaningful middle group needs a careful, individualized conversation with their physician before starting. This guide is the honest version of that conversation.

Why Cardiovascular Status Matters

During a ketamine session, three things happen to your cardiovascular system. Heart rate rises by roughly 5 to 15 bpm. Blood pressure rises by roughly 10 to 25 mmHg systolic (we have a dedicated guide on the BP question). And sympathetic nervous system activity transiently increases. These effects peak about thirty to sixty minutes into a session and resolve within sixty to ninety minutes of the dose ending.

For patients with a healthy cardiovascular system, that profile is trivial. For patients with certain heart conditions, it's a meaningful stress that has to be accounted for. Most of the work of a careful intake is figuring out which group you're in.

Conditions Usually Compatible with At-Home Treatment

With appropriate workup and stability, most of the common cardiovascular diagnoses don't disqualify patients. Well-controlled hypertension is fine; we have a separate piece walking through the BP specifics. Stable coronary artery disease that's been treated and asymptomatic is generally fine, as is a prior MI more than twelve months out provided the recovery has been clean and the medication regimen is stable. Stable atrial fibrillation, rate-controlled and appropriately anticoagulated, doesn't preclude treatment. Patients with healed coronary stents are usually appropriate after at least six months and with cardiologist clearance. Mild valvular disease (a murmur without symptoms or exercise limitation) and well-controlled NYHA Class I heart failure with stable weight and no recent hospitalizations are also generally compatible.

In every one of these cases, what I want to know is the same: is the condition stable, are you on appropriate medications, when was your last cardiology follow-up, and have you had any recent symptoms.

Conditions That Usually Require Clinic-Based Treatment

Some cardiac histories tip the risk-benefit calculation toward in-person monitoring, where immediate intervention is possible if something goes wrong. The list is fairly stable across reputable programs:

• Recent MI (within 12 months)
• Unstable or crescendo angina
• Severe aortic stenosis
• Significant ventricular arrhythmias: sustained VT, prior cardiac arrest, ICD placed for arrhythmia
• Moderate-to-severe heart failure: NYHA Class III–IV, EF below 30%
• Active endocarditis
• Aortic aneurysm or dissection history
• Uncontrolled hypertension that hasn't yet been managed

This isn't a blanket "no ketamine" for these patients. It's a "no at-home ketamine." A clinic setting with continuous cardiac monitoring is the appropriate place for treatment, if treatment is appropriate at all. In those cases, your cardiologist and a ketamine prescriber should coordinate directly.

Conditions That Are Case-by-Case

A few diagnoses really do depend on the specifics. Pacemakers and ICDs are usually compatible, though your device should be reviewed; ketamine shouldn't interfere with function, but any unusual symptom during a session deserves a same-week device interrogation. Prior PCI with a recent stent depends on how recent, what kind of stent, and where you are with dual antiplatelet therapy. Congenital heart disease varies enormously and needs an individualized opinion. Prior cardiac surgery is more about the stability of the surgical result than the surgery itself. Hypertrophic cardiomyopathy is one I tend to manage cautiously; the elevated sympathetic tone during a session is a real concern, and a clinic setting is often the better fit.

What Your Ketamine Physician Needs to See

If you have any cardiac history, your intake should include the exact diagnosis and when it was made, any procedures (stents, bypass, ablation, valve repair or replacement, device implantation), your current cardiac medications with doses, the most recent echocardiogram or stress test results if you have them, the name and contact of your current cardiologist, any symptoms in the last six months (chest pain, palpitations, shortness of breath, syncope), and your current exercise tolerance: how many flights of stairs before you have to stop.

A good intake process catches the cases where at-home isn't appropriate, and gives clear sign-off on the cases where it is.

Medications to Flag Specifically

Several cardiovascular medications matter for ketamine sessions, mostly in benign ways. Beta blockers (metoprolol, atenolol, carvedilol) are generally protective during sessions, blunting the HR and BP rise. Calcium channel blockers, ACE inhibitors, ARBs, and most antiarrhythmics at stable doses are compatible. Nitrates are fine to be on, though you shouldn't take sublingual nitroglycerin during a session. Anticoagulants (warfarin, apixaban, rivaroxaban) are fully compatible; ketamine does not interact with anticoagulation. For a broader medication review, see Is My Medication Safe with Ketamine?.

If You Don't Know Your Cardiac Status

A surprising number of patients come to ketamine therapy without ever having had a formal cardiovascular workup. If you're over fifty, have traditional risk factors (hypertension, diabetes, smoking history, family history of early coronary disease), or have noticed chest discomfort or exercise intolerance, it's worth getting a basic workup with your primary care doctor before starting any new medication, not just ketamine.

This is less about ketamine being uniquely risky and more about not evaluating a new treatment against an unknown baseline.

The Bottom Line

At-home ketamine is a good option for patients whose mental health needs are real, whose cardiovascular health is stable, and whose physician has a clear picture of both. It's a bad option for patients whose cardiovascular status is fragile, unstable, or unknown. If you're in the middle "not sure" zone, the right move is almost always to get the workup first and then decide. Not the other way around.

Cardiovascular conditions are just one piece of the eligibility picture. For the full screening checklist that covers psychiatric, neurological, substance-use, and other systemic conditions, see our ketamine therapy contraindications and eligibility guide.

Frequently Asked Questions

Is ketamine safe if you have heart disease?

It depends on the specific condition and stability. Stable coronary artery disease (treated, asymptomatic), prior MI more than 12 months out with clean recovery, well-controlled hypertension, rate-controlled atrial fibrillation, and well-controlled NYHA Class I heart failure are generally compatible with at-home ketamine. Recent MI, unstable angina, severe aortic stenosis, significant ventricular arrhythmias, NYHA Class III-IV heart failure, and aortic aneurysm history typically require clinic-based treatment instead.

Can you do ketamine therapy after a heart attack?

Generally not within 12 months of an MI. Recent myocardial infarction is on the list of conditions that require clinic-based treatment with continuous cardiac monitoring rather than at-home administration. After 12 months of stable recovery on appropriate medications and with cardiologist clearance, at-home treatment becomes a possibility, case-by-case based on residual ejection fraction, ongoing symptoms, and overall stability.

Is ketamine safe with atrial fibrillation?

Yes, generally; stable atrial fibrillation that's rate-controlled and appropriately anticoagulated doesn't preclude at-home ketamine treatment. Anticoagulants (warfarin, apixaban, rivaroxaban) are fully compatible with ketamine and don't interact pharmacologically. The cautions apply to unstable, rapid, or new-onset AFib, which warrant cardiology workup before considering ketamine therapy.

Can you take ketamine with a pacemaker or ICD?

Pacemakers and ICDs are usually compatible with ketamine therapy. Ketamine shouldn't interfere with device function, but any unusual symptom during a session deserves a same-week device interrogation as a precaution. ICDs placed specifically for ventricular arrhythmias warrant more careful review; significant ventricular arrhythmias are on the clinic-only list, and the ICD itself isn't the issue but the underlying arrhythmia is.

Does ketamine raise heart rate?

Yes, transiently. The average increase during a session is 5-15 bpm, peaking 30-60 minutes after the dose and resolving within 60-90 minutes of session end. For patients with healthy cardiovascular systems this is trivial. For patients with significant cardiac disease, it's a meaningful stress that has to be accounted for. Beta blockers blunt this response and are typically considered protective.

Should I get cardiac clearance before ketamine therapy?

If you're over 50, have traditional risk factors (hypertension, diabetes, smoking history, family history of early coronary disease), or have noticed chest discomfort or exercise intolerance, yes; get a basic cardiovascular workup with your primary care doctor before starting any new medication, not just ketamine. If you have a known cardiac history, your ketamine physician will want to coordinate directly with your cardiologist before approving treatment.

Can you do ketamine therapy with hypertrophic cardiomyopathy?

Cautiously, and often in a clinic setting rather than at home. The elevated sympathetic tone during a ketamine session is a real concern with hypertrophic cardiomyopathy; the temporary BP and heart rate increase can worsen the obstructive physiology in some HCM variants. Most prescribers manage these patients in clinic with continuous monitoring rather than at-home, and only after coordination with the patient's cardiologist.

What's the highest-risk cardiovascular condition for at-home ketamine?

Recent MI (within 12 months), unstable or crescendo angina, severe aortic stenosis, significant ventricular arrhythmias, moderate-to-severe heart failure (NYHA III-IV with EF below 30%), active endocarditis, and aortic aneurysm or dissection history are the conditions that most clearly tip the risk-benefit calculation toward clinic-based treatment with continuous monitoring rather than at-home administration.

Ready for a Cardiac-Aware Eligibility Review?

I'm a board-certified physician with internal medicine training. Cardiovascular risk stratification is a core part of that work, and I take a careful look at every cardiac history during intake. If at-home treatment is the right fit, I'll say so. If a clinic referral is safer, I'll say that too.

The five-minute eligibility check includes a cardiac history section. The earlier I see your full picture, the more quickly I can give you a clear answer. Check your eligibility.